BioSpace News Archive

Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference (“ddRNAi”) platform, today announced that Jerel A. Banks , M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec

Agilent Technologies Inc. (NYSE: A) today announced the release of the SureSelect XT HS2 RNA Reagent Kit . This solution features a modular design that enables a simple and parallel approach for both RNA and DNA samples, allowing customers to streamline and consolidate their workflow without losing time optimizing different kits for different s

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Morgan Stanley 18 th Annual Global Healthcare Conference being held virtually. AtriCure’s management is scheduled to pr

Sepsis Upgrade of KATE™ Triage Solution Achieves 50% Improvement in Early Sepsis Detection Accuracy Over Prior Best Practice Screening Protocol

Fiscal fourth quarter revenues increase 133.7% over the prior year Fiscal 2020 revenues increase 28.7% over fiscal 2019 New InFoods ® patent granted for Singapore

The Challenge recognizes Patient Entrepreneurs with solutions that aid successful, long-term recovery from alcohol and opioid use disorders [01-September-2020] UPPSALA, Sweden and NEW YORK , Sept. 1, 2020 /PRNewswire/ -- Orexo, a Swedish pharmaceutical company focused on improved pharmaceuticals and digital therapies, and Lyfebulb, a patient empowerment platform, an

Stryker’s AxSOS 3 ® Ankle Fusion System Offers Innovative Plates That Are Designed to Fit a Range of Patients New System Includes Titanium Plates with Streamlined Instrumentation and Updated Screw Offerings MAHWAH, N.J.--( BUSINESS WIRE )-- Stryker’s Trauma & Extremities division today announced the launch of its AxSOS 3 Ankle Fusion System, an ankle fusion titanium plate system intended for the fusion of the tibio-talar joint. This press rele

International clinical development program of nomacopan for the potential treatment of COVID-19 pneumonia announced Pivotal Phase III study in patients with bullous pemphigoid (BP) expected to start H1 2021 following recent successful end-of-Phase II meeting with FDA Enrollment in the pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) pivotal program expected to commence in Q4 2020 NEW YORK and LONDON, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Akar

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it has appointed Ernie Meyer as Executive Vice President and Chief Human Resources Officer, effective September 1, 2020.

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today its latest statistics regarding COVID-19 testing at Frankfurt and Hamburg Airports